LEADER 01350nam--2200373---450- 001 990001017070203316 005 20050511140932.0 010 $a90-272-3715-8 035 $a0101707 035 $aUSA010101707 035 $a(ALEPH)000101707USA01 035 $a0101707 100 $a20020305d2001----km-y0itay0103----ba 101 $aeng 102 $aNL 105 $a||||||||001yy 200 1 $aWhose german?$ethe act/ich alternation and related phenomena in 'standard' and colloquial$fOrrin W.Robinson 210 $aAmsterdam [etc.]$cJohn Benjamins Publishing Company$dcopyr.2001 215 $aIX, 169 p.$d23 cm 225 2 $aAmsterdam studies in the theory and history of linguistic science$iCurrent issues in linguistic theory$hSez.4.$v208 410 0$12001$aAmsterdam studies in the theory and history of linguistic science$iCurrent issues in linguistic theory$hSez.4. 606 0 $aLingua tedesca$xFonetica 676 $a431.5 700 1$aROBINSON,$bOrrin W.$0175609 912 $a990001017070203316 951 $aVII.2.D. 27(XII C 37)$b160122 L.M.$cXII C$d00077217 959 $aBK 969 $aUMA 979 $aPAOLA$b90$c20020305$lUSA01$h1722 979 $c20020403$lUSA01$h1743 979 $aPATRY$b90$c20040406$lUSA01$h1710 979 $aCOPAT2$b90$c20050511$lUSA01$h1409 996 $aWhose German$9542082 997 $aUNISA LEADER 01931nam 2200553 450 001 9910787232703321 005 20200520144314.0 010 $a1-4214-1594-1 035 $a(CKB)3710000000324857 035 $a(EBL)3318867 035 $a(OCoLC)899212264 035 $a(SSID)ssj0001404598 035 $a(PQKBManifestationID)12536811 035 $a(PQKBTitleCode)TC0001404598 035 $a(PQKBWorkID)11382325 035 $a(PQKB)10288534 035 $a(MdBmJHUP)muse42615 035 $a(Au-PeEL)EBL3318867 035 $a(CaPaEBR)ebr11003287 035 $a(MiAaPQ)EBC3318867 035 $a(PPN)266773052 035 $a(EXLCZ)993710000000324857 100 $a20150122h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe antibiotic era $ereform, resistance, and the pursuit of a rational therapeutics /$fScott H. Podolsky 210 1$aBaltimore, Maryland :$cJohns Hopkins University Press,$d2015. 210 4$dİ2015 215 $a1 online resource (324 p.) 300 $aDescription based upon print version of record. 311 $a1-4214-1593-3 320 $aIncludes bibliographical references and index. 327 $aSetting the stage : the origins of antibiotic reform -- Antibiotics and the invocation of the controlled clinical trial -- From sigmamycin to panalba : antibiotics and the FDA -- The limits to delimitation -- Responding to antibiotic resistance. 606 $aAntibacterial agents$zUnited States$xHistory 606 $aPharmaceutical industry$zUnited States 615 0$aAntibacterial agents$xHistory. 615 0$aPharmaceutical industry 676 $a616.92061 700 $aPodolsky$b Scott H.$0114580 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910787232703321 996 $aThe antibiotic era$93830808 997 $aUNINA